Biofunctional alendronate-Hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation

Biomaterials

Volumn 30, Issue 31, 2009, Pages 6168-6177

  Bigi, Adriana ^a   Boanini, Elisa ^a   Capuccini, Chiara ^a   Fini, Milena ^b   Mihailescu, Ion N ^c   Ristoscu, Carmen ^c   Sima, Felix ^c   Torricelli, Paola ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c NATIONAL INSTITUTE FOR LASER   (Romania)

Author keywords

Alendronate doped hydroxyapatite films; Bisphosphonate; MAPLE; Osteoblast; Osteoclast

Indexed keywords

ALENDRONATE; ALENDRONATE-DOPED HYDROXYAPATITE FILMS; AQUEOUS MEDIUM; BISPHOSPHONATE; BISPHOSPHONATES; CASPASE-3; CRYSTALLINITIES; CYTOKINE RECEPTOR; DIFFERENTIATION PARAMETERS; HYDROXYAPATITE COMPOSITE; HYDROXYAPATITE THIN FILMS; INFLAMMATORY REACTION; INTERLEUKIN-6; LIQUID NITROGEN TEMPERATURE; MAPLE; MATRIX ASSISTED PULSED LASER EVAPORATION; MG63 CELLS; NECROSIS FACTORS; OSTEOBLAST DIFFERENTIATION; OSTEOCALCIN; OSTEOCLAST; OSTEOCLAST PROLIFERATION; POROUS-LIKE STRUCTURES; REDUCED PRODUCTION; TITANIUM SUBSTRATES; TYPE I COLLAGEN;

APATITE; DEIONIZED WATER; DEPOSITION; EVAPORATION; EXCIMER LASERS; GAS LASERS; KRYPTON; LASER PULSES; LIQUID NITROGEN; PULSED LASER APPLICATIONS; THIN FILMS; TITANIUM; TUMORS; VAPORS;

HYDROXYAPATITE;

ALENDRONIC ACID; CASPASE 3; COLLAGEN TYPE 1; CYTOKINE RECEPTOR; HYDROXYAPATITE; INTERLEUKIN 6; LIQUID NITROGEN; NANOCRYSTAL; NITROGEN DERIVATIVE; OSTEOCALCIN; OSTEOPROTEGERIN; TITANIUM; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AQUEOUS SOLUTION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; INFLAMMATION; MATRIX ASSISTED PULSED LASER EVAPORATION; OSTEOBLAST; OSTEOCLAST; POROSITY; PRESSURE; PRIORITY JOURNAL; SUSPENSION; TECHNIQUE; TEMPERATURE;

ALENDRONATE; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; DURAPATITE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; OSTEOBLASTS; TITANIUM; X-RAY DIFFRACTION;

EID: 69649088493     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.07.066     Document Type: Article

References (34)

1. Boanini E., Gazzano M., Rubini K., and Bigi A. Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure. Adv Mater 19 (2007) 2499-2502
2. Fleisch H. Bisphosphonates in bone disease, from the laboratory to the patient (2000), Academic Press, San Diego
3. Adami S. Bisphosphonate antifracture efficacy. Bone 41 (2007) S8-S15
4. Chesnut III C., Skag A., Christiansen C., Recker R., Stakkestad J.A., Hoiseth A., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19 (2004) 1241-1249
5. Ott S.M. Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90 (2005) 1897-1899
6. Woo S.B., Hellstein J.W., and Kalmar J.R. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753-761
7. Boanini E., Torricelli P., Gazzano M., Giardino R., and Bigi A. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Biomaterials 29 (2008) 790-796
8. Bigi A., Bracci B., Cuisinier F., Elkaim R., Fini M., Mayer I., et al. Human osteoblast response to pulsed laser deposited calcium phosphate coatings. Biomaterials 26 (2005) 2381-2389
9. Capuccini C., Torricelli P., Sima F., Boanini E., Ristoscu C., Bracci B., et al. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response. Acta Biomater 4 (2008) 1885-1893
10. Bubb D.M., Wu P.K., Horwitz J.S., Callahan J.H., Galicia M., Vertes A., et al. The effect of the matrix on film properties in matrix-assisted pulsed laser evaporation. J Appl Phys 91 (2002) 2055-2058
11. Toftmann B., Papantonakis M.R., Auyeung R.C.Y., Kim W., O'Malley S.M., Bubb D.M., et al. UV and RIR matrix assisted pulsed laser deposition of organic MEH-PPV films. Thin Solid Films 453-454 (2004) 177-181
12. Sagawa J., Nagare S., and Senna M. Preparation and properties of bovine serum albumin thin films by pulsed laser deposition. Appl Surf Sci 244 (2005) 611-614
13. Tsuboi Y., Goto M., and Haya A. Pulsed laser deposition of silk protein: effect of photosensitized-ablation on the secondary structure in thin deposited films. J Appl Phys 89 (2001) 7917-7921
14. Taketani I., Nakayama S., Nagare S., and Senna M. The secondary structure control of silk fibroin thin films by post treatment. Appl Surf Sci 24 (2005) 623-626
15. Patz T., Cristescu R., Narayan R., Menegazzo N., Mizaikoff B., Messersmith P.B., et al. Laser deposition of fibrinogen blood proteins thin films by matrix assisted pulsed laser evaporation. Appl Surf Sci 248 (2005) 422-427
16. Gyorgy E., Sima F., Mihailescu I.N., Smausz T., Megyeri G., Kekesi R., et al. Immobilization of urease by laser techniques: synthesis and application to urea biosensors. J Biomed Mater Res A 89A (2008) 186-191
17. Negroiu G., Piticescu R.M., Chitanu G.C., Mihailescu I.N., Zdrentu L., and Miroiu M. Biocompatibility evaluation of a novel hydroxyapatite-polymer coating for medical implants (in vitro tests). J Mater Sci: Mater Med 19 (2008) 1537-1544
18. McLeod K., Anderson G.I., Dutta N.K., Smart R.S.C., Voelcker N.H., Sekel R., et al. Adsorption of bisphosphonate onto hydroxyapatite using a novel co-precipitation technique for bone growth enhancement. J Biomed Mater Res A 79A (2006) 271-281
19. Peter B., Pioletti D.P., Laib S., Bujoli B., Pilet P., Janvier P., et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 36 (2005) 52-60
20. Kuljanin J., Janković I., Nedeljković J., Prstojević D., and Marinković V. Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions. J Pharm Biomed Anal 28 (2002) 1215-1220
21. Giordano C., Sandrini E., Del Curto B., Signorelli E., Rondelli G., and Di Silvio L. Titanium for osteointegration: comparison between a novel biomimetic treatment and commercially exploited surfaces. J Appl Biomater Biomech 2 (2004) 35-44
22. Anselme K. Osteoblast adhesion on biomateials. Biomaterials 21 (2000) 667-681
23. Reyes C.D., Petrie T.A., Burns K.L., Schwartz Z., and García A.J. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 28 (2007) 3228-3235
24. Rae T. Tissue culture techniques in biocompatibility testing. In: Williams D.F. (Ed). Techniques of biocompatibility testing (1986), CRC Press, Boca Raton 81-93
25. Stein G.S., and Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationship during progressive development of the osteoblast phenotype. Endocr Rev 14 (1993) 424-442
26. Gori F., Hofbauer L.C., Dunstan C.R., Spelberg T.C., Khosla S., and Riggs B.L. The expression of osteoprotegerin and rank ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141 (2000) 4768-4776
27. Kishimoto T., Akira S., and Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258 5082 (1992) 593-597
28. MacEwan D.J. TNF ligands and receptors - a matter of life and death. Br J Pharmacol 135 (2002) 855-875
29. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
30. Nakashima A., and Tamura M. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Front Biosci 11 (2006) 1667-1678
31. Wolf B.B., and Green D.R. Suicidal tendencies: apoptotic cell death by caspase family proteinase. J Biol Chem 274 (1999) 20049-20052
32. Hughes D.E., Wright K.R., Uy H.L., Sasaki A., Yoneda T., Roodman G.D., et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10 (1995) 1478-1487
33. Bonewald L.F., Oreffo R.0.C., Seyedin S., and Mundy G.R. Isolated osteoclasts activate latent TGFfl. J Bone Miner Res 3 (1988) S98
34. Janssens K., ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-β1 to the bone. Endocr Rev 26 (2005) 743-774